The Asia Pacific Patient Innovation Summit publishes a whitepaper, which serves as a blueprint to help patient organizations improve their approach to sustainable funding, digitalization, and multi-stakeholder partnerships.

Novartis is committed to transforming the lives of people living with blood cancers and serious blood disorders.

Novartis COVID-19 Response Fund is providing urgently-needed support for healthcare workers and communities in over 50 projects around the world.

Latest oncology resources and news surrounding Novartis data featured at European Society for Medical Oncology (ESMO)

Together in spirit. Find out how our associates all over the world are joining together to make a difference as we celebrate Pride 2020.

Standing by people with sickle cell disease and their families

As a company, we stand up for greater inclusion of LGBTI people because when each of us feels included, we all benefit.

Novartis condemns the war in Ukraine and has been providing humanitarian support, financial donations as well as considerable volumes of medicines to those people impacted by the war.

Novartis is committed to reimagining the fight against Chagas Disease and advocating for an integrated, end-to-end care approach.

COVID-19 is disrupting Africa’s health services – potentially undermining decades of progress on child health.